Original Research
Published on 20 Apr 2022
The Expression of Cytokine Profiles and Related Receptors in Idiopathic Inflammatory Myopathies
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.852055
- 4,298 views
- 8 citations
Type at least 3 characters
1,646 articles
Articles
Case Report
Published on 20 Apr 2022
Observation of Voriconazole in the Treatment of Liver Failure Complicated With Invasive Pulmonary Fungal Infection Induced by Chinese Patent Medicine in Teenagers: 2 Case Reports
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.862222
- 2,927 views
- 2 citations
Original Research
Published on 20 Apr 2022
A Novel Epithelial-Mesenchymal Transition Gene Signature Correlated With Prognosis, and Immune Infiltration in Hepatocellular Carcinoma
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.863750
- 3,206 views
- 6 citations
Original Research
Published on 20 Apr 2022
Variation in the Efficacy of Anti-Ulcerative Colitis Treatments Reveals the Conflict Between Precipitating Compatibility of Traditional Chinese Medicine and Modern Technology: A Case of Scutellaria-Coptis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.819851
- 3,252 views
- 9 citations
Original Research
Published on 20 Apr 2022
A Series of Genes for Predicting Responses to Anti-Tumor Necrosis Factor α Therapy in Crohn’s Disease
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.870796
- 4,022 views
- 5 citations
Original Research
Published on 20 Apr 2022
BI 1015550 is a PDE4B Inhibitor and a Clinical Drug Candidate for the Oral Treatment of Idiopathic Pulmonary Fibrosis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.838449
- 39,579 views
- 53 citations
Original Research
Published on 20 Apr 2022
Orphan Nuclear Receptor NR4A2 Is Constitutively Expressed in Cartilage and Upregulated in Inflamed Synovium From hTNF-Alpha Transgenic Mice
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.835697
- 4,048 views
- 4 citations
Original Research
Published on 20 Apr 2022
SIRT6 Activator UBCS039 Inhibits Thioacetamide-Induced Hepatic Injury In Vitro and In Vivo
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.837544
- 3,033 views
- 10 citations
Brief Research Report
Published on 19 Apr 2022
Dysfunction of Inflammatory Pathways and Their Relationship With Psychological Factors in Adult Female Patients With Eating Disorders
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.846172
- 2,851 views
- 2 citations
Original Research
Published on 14 Apr 2022
Efficacy and Safety of Lithium Treatment in SARS-CoV-2 Infected Patients
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.850583
- 18,475 views
- 8 citations
Editorial
Published on 12 Apr 2022
Editorial: Natural Product Based Drugs that Control Obesity and Other Disorders that Trigger and Provoke Inflammation
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.891496
- 1,186 views
- 2 citations
Review
Published on 12 Apr 2022
New Advances on Pathophysiology of Diabetes Neuropathy and Pain Management: Potential Role of Melatonin and DPP-4 Inhibitors
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.864088
- 8,404 views
- 4 citations
Review
Published on 11 Apr 2022
Mechanisms and Therapeutic Strategies of Viral Myocarditis Targeting Autophagy
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.843103
- 4,890 views
- 8 citations
Original Research
Published on 06 Apr 2022
Inflammation Affects Liver Function and the Metabolism of Voriconazole to Voriconazole-N-Oxide in Adult and Elderly Patients
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.835871
- 2,651 views
- 13 citations
Original Research
Published on 06 Apr 2022
RRx-001 Exerts Neuroprotection Against LPS-Induced Microglia Activation and Neuroinflammation Through Disturbing the TLR4 Pathway
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.889383
- 3,784 views
- 15 citations
Review
Published on 06 Apr 2022
Gasdermin E: A Prospective Target for Therapy of Diseases
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.855828
- 11,468 views
- 22 citations